SEP 2, 2026 · JOURNAL ARTICLE
Integrating the liver into the cardiovascular-kidney-metabolic syndrome: pathophysiology and therapeutic implications
Current Opinion in Nephrology & Hypertension
A narrative review synthesizing mechanistic, epidemiological, and therapeutic evidence to recommend integration of liver assessment into cardiovascular-kidney-metabolic risk stratification and therapy selection in clinical practice.
Reported
Regulatory approval (resmetirom)FDA-accelerated approval March 2024; Europe…
Regulatory approval (semaglutide…FDA accelerated approval and EU marketing a…